Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT).

Details

Language :

English

ISSN :

1879-0852

Volume :

156 Suppl 1

Database :

MEDLINE

Journal :

European journal of cancer (Oxford, England : 1990)

Publication Type :

Academic Journal

Accession number :

34649647

Full Text :

https://doi.org/10.1016/S0959-8049(21)00668-7